USPTO serial 99046894
MINDWALK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2026
- Examiner
- CHADAB, SETH WILLIG
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MINDWALK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
VICTORIA, CA
VICTORIA, CA
Victoria, BC, CA
Victoria, BC, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott W. Johnston
Scott W. Johnston Merchant & Gould P.C.P.O. Box 2910Minneapolis, MN 55402-0910United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Antibodies for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, diagnostic veterinary research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use, and scientific use | ACTIVE | Nov 17, 2025 |
| 040 | Biomanufacturing for others, namely, generation and purification of antibodies for research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use, and scientific use; Biomanufacturing for others, namely, generation and purification of antibodies for therapeutic medical use, diagnostic veterinary use and therapeutic veterinary use | ACTIVE | Nov 17, 2025 |
| 042 | Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based solution to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data; biological laboratory services; biological research and analysis, and development of biological samples, genetical, protein or sequence related data for medical use; biological laboratory services, namely, sequencing of biological samples, including DNA and RNA and analysis thereof; biological research, development and analysis of biological samples, including DNA and RNA; biological research, namely, identification and characterization of biopolymers, biological samples, biological sequences and biological particles; DNA sequencing services for therapeutic use, research use, scientific diagnostic use, diagnostic research use, diagnostic medical research use, industrial scientific use, industrial research use, use in industrial manufacturing processes, laboratory research use and scientific use; Storage services for archiving electronic data, namely, electronic copies of DNA sequences; DNA sequencing services for scientific research purposes; Scientific and technological services as well as research and design relating thereto, namely, the development of a cloud-based solution to perform genetic research by applying algorithmic principles for the quick retrieval of biological sequence data on all molecular layers to enable analysis of big data and by applying algorithms for structural search and modelling; scientific and technological services, namely, scientific research, analysis and testing in the field of biology, biotechnology, genetics, pharmacy and medicine; biological research, development and analysis; biological analysis of biological samples, genetical, protein or sequence related data for medical use; Providing temporary used of non-downloadable cloud computing software for use in database management of biological samples, multi-omics, genetical, protein or sequence related data; Platform as a service (PAAS) featuring computer software platforms for database management of biological samples, multi-omics, genetical, protein or sequence related data; Software as a service (SAAS) services featuring software for database management of biological samples, multi-omics, genetical, protein or sequence related data | ACTIVE | Nov 17, 2025 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MINDWALK HOLDINGS CORP.
- Other trademarks owned by MINDWALK HOLDINGS CORP.
- Other trademarks owned by Immunoprecise Antibodies LTD.
- Other trademarks owned by Immunoprecise Antibodies LTD.
- Other trademarks in Class 001
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named MINDWALK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 1, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 1, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 13, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 13, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jul 7, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 21, 2026 | IUAF | USE AMENDMENT FILED | — |
| Apr 21, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 11, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 21, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 26, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 26, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 25, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 9, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 19, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 19, 2025 | NWAP | NEW APPLICATION ENTERED | — |